Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Combined Effect of Botulinum Toxin Type A and Mirror Therapy in the Management of Chronic-Phase Upper Extremity Spasticity After Ischemic Stroke: A Double-Blind, Controlled Study

NCT07331844 is registered in ClinicalTrials.gov with Fatih Sultan Mehmet Training and Research Hospital as lead sponsor.

NCT NCT07331844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07331844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Combined Effect of Botulinum Toxin Type A and Mirror Therapy in the Management of Chronic-Phase Upper Extremity Spasticity After Ischemic Stroke: A Double-Blind, Controlled Study
Lead sponsor
Fatih Sultan Mehmet Training and Research Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 15, 2024
Completion date
May 15, 2025
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spastic hemiplegia, stroke